| 标题 |
Final clinical data of a phase 1 dose‐escalation study of WVT078, a BCMA×CD3 bispecific antibody, alone and in combination with γ‐secretase inhibitor WHG626 in patients with relapsed and/or refractory multiple myeloma |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer 作者:Fredrik Schjesvold; Andrew Spencer; Yael C. Cohen; Enrique M. Ocio; Jordi Lopez‐Pardo; et al 出版日期:2026 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)